The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Mallinckrodt Plc

NYSE: MNK
Last

(U.S.) $119.46

Today's change-0.81 -0.67%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.
 

Mallinckrodt Plc

NYSE: MNK
Last

(U.S.) $119.46

Today's change-0.81 -0.67%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Mallinckrodt Plc down (U.S.)$0.81

Mallinckrodt Plc closed lower Thursday, dropping (U.S.)$0.81 or 0.67% to (U.S.)$119.46. Over the last five days, shares have gained 2.29% and 20.63% year to date. Shares have outperformed the S&P 500 by 42.39% during the last year.

Key company metrics

  • Open(U.S.) $120.68
  • Previous close(U.S.) $120.27
  • High(U.S.) $120.69
  • Low(U.S.) $118.37
  • Bid / Ask-- / --
  • YTD % change+20.63%
  • Volume1,030,142
  • Average volume (10-day)1,181,368
  • Average volume (1-month)1,147,543
  • Average volume (3-month)1,203,879
  • 52-week range(U.S.) $67.18 to (U.S.) $134.26
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.09×
  • Forward PEG0.66×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$3.12
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-6.47%

Although this company's net profit margin is negative, it is above the industry average and implies that Mallinckrodt Plc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.30%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 27, 201503/27/2015Dec 26, 201412/26/2014Sep 26, 201409/26/2014Jun 27, 201406/27/2014
Revenue910866789653
Total other revenue--------
Total revenue910866789653
Gross profit489439401284
Total cost of revenue421428389369
Total operating expense8157391,146658
Selling / general / administrative344263281221
Research & development47424443
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3643023
Other operating expenses, total0032
Operating income95127-357-4
Interest income (expense), net non-operating-57-49-38-23
Gain (loss) on sale of assets--------
Other--------
Income before tax4283-391-27
Income after tax7792-352-24
Income tax, total-34-9-39-2
Net income9993-352-24
Total adjustments to net income--------
Net income before extra. items7792-352-24
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items7792-352-24
Inc. avail. to common incl. extra. items9993-352-24
Diluted net income9993-352-24
Dilution adjustment----00
Diluted weighted average shares1171168559
Diluted EPS excluding extraordinary itemsvalue per share0.650.79-4.15-0.42
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.670.83-0.86-0.16